Menu
Back to Journals » OncoTargets and Therapy » Volume 14
Hsa_circ_0006916 Knockdown Represses the Development of Hepatocellular Carcinoma via Modulating miR-599/SRSF2 Axis [Retraction]
Zhu Z, Shen S, Zhao S, Wang Z. Onco Targets Ther. 2020;13:11301–11313.
At the authors request, the Editor and Publisher of OncoTargets and Therapy wish to retract the published article. The authors informed the journal that the author, Sen Zhao, was added to the paper as an author without their knowledge or permission. In addition, the authors have also informed the journal that no ethical approval was given by the ethics committee of the First Affiliated Hospital of Henan University despite the article stating research approval had been provided. Given both issues breach our editorial policies the authors decided to retract the article.
Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
© 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.